rs7641889

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006218.4(PIK3CA):​c.-77+20218C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0855 in 152,050 control chromosomes in the GnomAD database, including 597 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. The gene PIK3CA is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.085 ( 597 hom., cov: 32)

Consequence

PIK3CA
NM_006218.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0590

Publications

12 publications found
Variant links:
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
PIK3CA Gene-Disease associations (from GenCC):
  • overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • megalencephaly-capillary malformation-polymicrogyria syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • vascular malformation
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 5
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006218.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIK3CA
NM_006218.4
MANE Select
c.-77+20218C>T
intron
N/ANP_006209.2P42336

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIK3CA
ENST00000263967.4
TSL:2 MANE Select
c.-77+20218C>T
intron
N/AENSP00000263967.3P42336
PIK3CA
ENST00000955190.1
c.-77+20218C>T
intron
N/AENSP00000625249.1
PIK3CA
ENST00000876545.1
c.-77+19105C>T
intron
N/AENSP00000546604.1

Frequencies

GnomAD3 genomes
AF:
0.0854
AC:
12976
AN:
151932
Hom.:
597
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.122
Gnomad AMR
AF:
0.0985
Gnomad ASJ
AF:
0.0444
Gnomad EAS
AF:
0.0968
Gnomad SAS
AF:
0.0779
Gnomad FIN
AF:
0.0870
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.0713
Gnomad OTH
AF:
0.0771
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0855
AC:
12995
AN:
152050
Hom.:
597
Cov.:
32
AF XY:
0.0868
AC XY:
6450
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.106
AC:
4387
AN:
41498
American (AMR)
AF:
0.0995
AC:
1521
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0444
AC:
154
AN:
3466
East Asian (EAS)
AF:
0.0966
AC:
499
AN:
5164
South Asian (SAS)
AF:
0.0778
AC:
375
AN:
4822
European-Finnish (FIN)
AF:
0.0870
AC:
914
AN:
10502
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.0713
AC:
4845
AN:
67988
Other (OTH)
AF:
0.0763
AC:
161
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
593
1186
1780
2373
2966
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0758
Hom.:
251
Bravo
AF:
0.0891
Asia WGS
AF:
0.0760
AC:
265
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.1
DANN
Benign
0.81
PhyloP100
-0.059
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7641889; hg19: chr3-178886609; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.